Michael F MacLean Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael F MacLean.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael F MacLean. Michael F MacLean is SVP, Chief Accounting Officer in BIOGEN INC. ($IDPH) and Chief Financial Officer in Avidity Biosciences, Inc. ($RNA) and Chief Financial Officer in AKCEA THERAPEUTICS, INC. ($AKCA).
Latest Insider Trading Transactions of Michael F MacLean
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKCA, RNA, IDPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2021 | RNA | Avidity Bioscience ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 22.34 | 92,000 | 2,055,280 | 92,000 | |
| Jan 16 2020 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Grant | A | 0.00 | 28,000 | 0 | 48,000 | 20 K to 48 K (+140.00 %) |
| Jan 03 2020 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 16.99 | 57,000 | 968,430 | 57,000 | |
| Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 30.73 | 83,000 | 2,550,590 | 83,000 | |
| Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 17.38 | 30,000 | 521,400 | 30,000 | |
| Sep 05 2017 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 18.65 | 332,708 | 6,205,004 | 332,708 | |
| Mar 23 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 60.00 | 4,085 | 245,100 | 20,314 | 24.4 K to 20.3 K (-16.74 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 6,114 | 0 | 6,114 | |
| Feb 25 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 55.29 | 427 | 23,609 | 24,399 | 24.8 K to 24.4 K (-1.72 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 55.29 | 423 | 23,388 | 24,826 | 25.2 K to 24.8 K (-1.68 %) |
| Feb 25 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Grant | A | 0.00 | 3,990 | 0 | 25,249 | 21.3 K to 25.2 K (+18.77 %) |
| Feb 17 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 55.21 | 875 | 48,309 | 21,259 | 22.1 K to 21.3 K (-3.95 %) |
| Feb 17 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 55.21 | 1,127 | 62,222 | 22,134 | 23.3 K to 22.1 K (-4.85 %) |
| Jan 19 2010 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 55.00 | 1,389 | 76,395 | 23,261 | 24.7 K to 23.3 K (-5.63 %) |
| Nov 03 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 1,000 | 0 | 0 | |
| Nov 03 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 42.13 | 418 | 17,610 | 24,650 | 25.1 K to 24.7 K (-1.67 %) |
| Nov 03 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Buy | M | 0.00 | 1,000 | 0 | 25,068 | 24.1 K to 25.1 K (+4.15 %) |
| Oct 05 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 49.34 | 953 | 47,021 | 24,068 | 25 K to 24.1 K (-3.81 %) |
| Feb 26 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | A | 49.65 | 10,715 | 532,000 | 10,715 | |
| Feb 26 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Grant | A | 0.00 | 4,030 | 0 | 24,600 | 20.6 K to 24.6 K (+19.59 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 52.61 | 1,132 | 59,555 | 20,570 | 21.7 K to 20.6 K (-5.22 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 52.61 | 875 | 46,034 | 21,702 | 22.6 K to 21.7 K (-3.88 %) |
| Nov 04 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 1,000 | 0 | 1,000 | |
| Nov 04 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 42.55 | 318 | 13,531 | 22,577 | 22.9 K to 22.6 K (-1.39 %) |
| Nov 04 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Buy | M | 0.00 | 1,000 | 0 | 22,895 | 21.9 K to 22.9 K (+4.57 %) |
| Oct 06 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 50.00 | 2,047 | 102,350 | 21,895 | 23.9 K to 21.9 K (-8.55 %) |
| Oct 02 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 49.59 | 953 | 47,259 | 23,942 | 24.9 K to 23.9 K (-3.83 %) |
| Aug 01 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | M | 47.77 | 1,875 | 89,569 | 5,625 | |
| Aug 01 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 72.77 | 1,875 | 136,444 | 24,895 | 26.8 K to 24.9 K (-7.00 %) |
| Aug 01 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Buy | M | 47.77 | 1,875 | 89,569 | 26,770 | 24.9 K to 26.8 K (+7.53 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 70.00 | 682 | 47,740 | 24,895 | 25.6 K to 24.9 K (-2.67 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.88 | 100 | 6,488 | 25,577 | 25.7 K to 25.6 K (-0.39 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.85 | 300 | 19,455 | 25,677 | 26 K to 25.7 K (-1.15 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.80 | 200 | 12,960 | 25,977 | 26.2 K to 26 K (-0.76 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.51 | 100 | 6,451 | 26,177 | 26.3 K to 26.2 K (-0.38 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.47 | 14 | 903 | 26,277 | 26.3 K to 26.3 K (-0.05 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.42 | 100 | 6,442 | 26,291 | 26.4 K to 26.3 K (-0.38 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.40 | 600 | 38,640 | 26,391 | 27 K to 26.4 K (-2.22 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.39 | 100 | 6,439 | 26,991 | 27.1 K to 27 K (-0.37 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 64.36 | 300 | 19,308 | 27,091 | 27.4 K to 27.1 K (-1.10 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 63.66 | 100 | 6,366 | 27,391 | 27.5 K to 27.4 K (-0.36 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Sell | S | 63.52 | 300 | 19,056 | 27,491 | 27.8 K to 27.5 K (-1.08 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | A | 60.56 | 23,130 | 1,400,753 | 23,130 | |
| Feb 14 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Grant | A | 0.00 | 8,260 | 0 | 27,326 | 19.1 K to 27.3 K (+43.32 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 60.56 | 1,120 | 67,827 | 19,066 | 20.2 K to 19.1 K (-5.55 %) |
| Nov 02 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | M | 0.00 | 1,000 | 0 | 2,000 | |
| Nov 02 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Payment of Exercise | F | 72.87 | 318 | 23,173 | 19,947 | 20.3 K to 19.9 K (-1.57 %) |
| Nov 02 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Buy | M | 0.00 | 1,000 | 0 | 20,265 | 19.3 K to 20.3 K (+5.19 %) |
| Oct 02 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Grant | A | 0.00 | 9,000 | 0 | 19,235 | 10.2 K to 19.2 K (+87.93 %) |
| Feb 14 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Option Exercise | A | 49.31 | 25,900 | 1,277,129 | 25,900 | |
| Feb 14 2007 | IDPH | BIOGEN INC. | MacLean Michael F | SVP, Chief Accounti ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1